{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:07:53Z","timestamp":1774652873445,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["A101205"],"award-info":[{"award-number":["A101205"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1129-1","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T08:44:31Z","timestamp":1470127471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom"],"prefix":"10.1186","volume":"17","author":[{"name":"BURQOL-RD Research Network","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Angelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Kanavos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"L\u00f3pez-Bastida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Linertov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Serrano-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"1129_CR1","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991\u20134.","journal-title":"J Rheumatol"},{"key":"1129_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2003.008516","volume":"63","author":"K Minden","year":"2004","unstructured":"Minden K, Niewerth M, Listing J, Biedermann T, Sch\u00f6ntube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis. 2004;63:836\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1129_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum. 2008;58:15\u201325.","journal-title":"Part I Arthritis Rheum"},{"key":"1129_CR4","first-page":"1975","volume":"23","author":"DP Symmons","year":"1996","unstructured":"Symmons DP, Jones M, Osborne J, Sills J, Southwood TR, Woo P. Pediatric rheumatology in the United Kingdom: data from the British pediatric rheumatology group national diagnostic register. J Rheumatol. 1996;23:1975\u201380.","journal-title":"J Rheumatol"},{"key":"1129_CR5","first-page":"1","volume":"35","author":"JL Huang","year":"2012","unstructured":"Huang JL. New advances in juvenile idiopathic arthritis. Chang Gung Med J. 2012;35:1\u201314.","journal-title":"Chang Gung Med J"},{"key":"1129_CR6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2007.07.006","volume":"33","author":"JE Weis","year":"2007","unstructured":"Weis JE, Ilowite NT. Juvenile idiopathic arthritis. Rheum Dis Clin N Am. 2007;33:441\u201370.","journal-title":"Rheum Dis Clin N Am"},{"key":"1129_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1546-0096-8-20","volume":"8","author":"LN Moorthy","year":"2010","unstructured":"Moorthy LN, Peterson MG, Hassett AL, Lehman TJ. Burden of childhood-onset arthritis. Pediatr Rheumatol Online J. 2010;8:20. doi: 10.1186\/1546-0096-8-20 .","journal-title":"Pediatr Rheumatol Online J"},{"key":"1129_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63:465\u201382.","journal-title":"Arthritis Care Res"},{"key":"1129_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1546-0096-12-35","volume":"12","author":"M Albarouni","year":"2014","unstructured":"Albarouni M, Becker I, Horneff G. Predictors of response to methotrexate in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2014;12:35.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1129_CR10","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"K Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Sch\u00f6ntube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392\u2013401.","journal-title":"Arthritis Rheum"},{"key":"1129_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1546-0096-11-24","volume":"11","author":"A Ens","year":"2013","unstructured":"Ens A, Lang B, Ramsey S, Stringer E, Huber AM. The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience. Pediatr Rheumatol Online J. 2013;11:24. doi: 10.1186\/1546-0096-11-24 .","journal-title":"Pediatr Rheumatol Online J"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00296-011-1894-y","volume":"32","author":"IK Yucel","year":"2012","unstructured":"Yucel IK, Seyahi E, Kasapcopur O, Arisoy N. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever. Rheumatol Int. 2012;32:1955\u201362. doi: 10.1007\/s00296-011-1894-y . Epub 2011 Apr 3.","journal-title":"Rheumatol Int"},{"key":"1129_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/rheumatology\/ken039","volume":"47","author":"J Thornton","year":"2008","unstructured":"Thornton J, Lunt M, Ashcroft DM, Baildam E, Foster H, Davidson J, et al. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology. 2008;47:985\u201390. doi: 10.1093\/rheumatology\/ken039 . Epub 2008 Apr 16.","journal-title":"Rheumatology"},{"key":"1129_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.22463","volume":"57","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Duffy C, Malleson P, Feldman DE, St Pierre Y, Clarke AE. Economic impact of juvenile idiopathic arthritis. Arthritis Rheum. 2007;57:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"1129_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1546-0096-12-34","volume":"12","author":"L Haverman","year":"2014","unstructured":"Haverman L, van Oers HA, Maurice-Stam H, Kuijpers TW, Grootenhuis MA, van Rossum MA. Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey. Pediatr Rheumatol Online J. 2014;12:34. doi: 10.1186\/1546-0096-12-34 . eCollection 2014.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1129_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.healthpol.2012.08.001","volume":"108","author":"R Linertov\u00e1","year":"2012","unstructured":"Linertov\u00e1 R, Serrano-Aguilar P, Posada-de-la-Paz M, Hens-P\u00e9rez M, Kanavos P, Taruscio D, on behalf of BURQOL-RD Research Group, et al. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy. 2012;108:19\u201326.","journal-title":"Health Policy"},{"key":"1129_CR17","unstructured":"Payment by Results in the NHS: tariff for 2012 to 2013. [ https:\/\/www.gov.uk\/government\/publications\/confirmation-of-payment-by-results-pbr-arrangements-for-2012-13 ]. Accessed 6 Nov 2015."},{"key":"1129_CR18","unstructured":"Curtis, L. Unit Costs of Health and Social Care 2012. [ http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2012\/ ]. Accessed 6 Nov 2015."},{"key":"1129_CR19","unstructured":"NHS reference costs 2012 to 2013. [ https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2012-to-2013 ]. Accessed 6 Nov 2015."},{"key":"1129_CR20","unstructured":"NHS Drug Tariff. [ http:\/\/www.ppa.org.uk\/ppa\/edt_intro.htm ]. Accessed 6 Nov 2015."},{"key":"1129_CR21","unstructured":"British National Formulary. [ http:\/\/www.bnf.org\/bnf\/index.htm ]. Accessed 6 Nov 2015."},{"key":"1129_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/gps.353","volume":"16","author":"D McDaid","year":"2001","unstructured":"McDaid D. Estimating the costs of informal care for people with Alzheimer\u2019s disease: methodological and practical challenges. Int J of Geriatr Psychiatry. 2001;16:400\u20135.","journal-title":"Int J of Geriatr Psychiatry"},{"key":"1129_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","volume":"60","author":"TA Hodgson","year":"1982","unstructured":"Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to assessment practices and procedures. Milbank Mem Fund Q. 1982;60:429\u201391.","journal-title":"Milbank Mem Fund Q"},{"key":"1129_CR24","unstructured":"Annual Survey of Hours and Earnings, 2012. [ http:\/\/www.ons.gov.uk\/ons\/rel\/ashe\/annual-survey-of-hours-and-earnings\/2012-provisional-results\/index.html ]. Accessed 6 Nov 2015."},{"key":"1129_CR25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"1129_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/09638288809164103","volume":"10","author":"C Collin","year":"1998","unstructured":"Collin C, Wade DT, et al. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1998;10:61\u20133.","journal-title":"Int Disabil Stud"},{"key":"1129_CR27","doi-asserted-by":"crossref","unstructured":"H\u00e9rbert R, Bravo G, Pr\u00e9ville M. Reliability, validity, and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia. Can J Aging. 2000;19:494\u2013507.","DOI":"10.1017\/S0714980800012484"},{"key":"1129_CR28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095\u2013108.","journal-title":"Med Care"},{"key":"1129_CR29","unstructured":"Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Discussion paper 172, 1999. The University of York Centre of Health Economics."},{"key":"1129_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","volume":"119","author":"A Angelis","year":"2015","unstructured":"Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119:964\u201379. doi: 10.1016\/j.healthpol.2014.12.016 .","journal-title":"Health Policy"},{"key":"1129_CR31","first-page":"952","volume":"19","author":"SH Allaire","year":"1992","unstructured":"Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JG. The economic impacts of juvenile rheumatoid arthritis. J Rheumatol. 1992;19:952\u20135.","journal-title":"J Rheumatol"},{"key":"1129_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6170","volume":"6","author":"C Cummins","year":"2002","unstructured":"Cummins C, Connock M, Fry-Smith A, Burls A. A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Health Technol Assess. 2002;6:1\u201343.","journal-title":"Health Technol Assess"},{"key":"1129_CR33","first-page":"S686","volume":"50","author":"H Brunner","year":"2004","unstructured":"Brunner H, Barron A, Graham T. Effects of treatment on costs &health-related quality of life (HRQL) of children with polyarticularcourse juvenile rheumatoid arthritis (JRA). Arthritis Rheum. 2004;50:S686.","journal-title":"Arthritis Rheum"},{"key":"1129_CR34","first-page":"863","volume":"27","author":"K Minden","year":"2009","unstructured":"Minden K, Niewerth M, Listing J, M\u00f6bius D, Thon A, Ganser G, et al. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. Clin Exp Rheumatol. 2009;27:863\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1129_CR35","first-page":"2286","volume":"31","author":"J Haapasaari","year":"2004","unstructured":"Haapasaari J, Kautiainen HJ, Isom\u00e4ki HA, Hakala M. Etanercept does not essentially increase the total costs of the treatment of refractory juvenile idiopathic arthritis. J Rheumatol. 2004;31:2286\u20139.","journal-title":"J Rheumatol"},{"key":"1129_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9390","volume":"9","author":"H Epps","year":"2005","unstructured":"Epps H, Ginnelly L, Utley M, Southwood T, Gallivan S, Sculpher M, et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathicarthritis. Health Technol Assess. 2005;9:1\u201359.","journal-title":"Health Technol Assess"},{"key":"1129_CR37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11136-005-3690-1","volume":"15","author":"KT April","year":"2006","unstructured":"April KT, Feldman DE, Platt RW, Duffy CM. Comparison between Children with Juvenile Idiopathic Arthritis (JIA) and their parents concerning perceived Quality of Life. Qual Life Res. 2006;15:655\u201361.","journal-title":"Qual Life Res"},{"key":"1129_CR38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.21852","volume":"55","author":"KL Shaw","year":"2006","unstructured":"Shaw KL, Southwood TR, Duffy CM, McDonagh JE. Health-related quality of life in adolescents with juvenile idiopathic arthritis. Arthritis Rheum. 2006;55:199\u2013207.","journal-title":"Arthritis Rheum"},{"key":"1129_CR39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-008-0672-y","volume":"29","author":"B Amine","year":"2009","unstructured":"Amine B, Rostom S, Benbouazza K, Abouqal R, Hajjaj-Hassouni N. Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis. Rheumatol Int. 2009;29:275\u20139.","journal-title":"Rheumatol Int"},{"key":"1129_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11999-007-0010-9","volume":"466","author":"BM Jolles","year":"2008","unstructured":"Jolles BM, Bogoch ER. Quality of life after TKA for patients with juvenile rheumatoid arthritis. Clin Orthop Relat Res. 2008;466:167\u201378.","journal-title":"Clin Orthop Relat Res"},{"key":"1129_CR41","unstructured":"Ghatnekar O, Glenng\u00e5rd AH, Olofsson S, Persson U. A literature review of instruments for measuring health-related quality of life in rare diseases. The Swedish Institute for Health Economics. Internal report of BURQOL-RD; 2011."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1129-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:44:22Z","timestamp":1498319062000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1129-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1129-1","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"article-number":"321"}}